BACKGROUND AND AIM: Progress in laboratory diagnostics of IgE-mediated allergy is the use of component-resolved diagnosis. Our study analyses the results of specific IgE to 295 allergen reagents (117 allergenic extracts and 178 molecular components) in patients suffering from atopic dermatitis (AD) with the use of ALEX2 Allergy Explorer. METHOD: The complete dermatological and allergological examination, including the examination of the sensitization to molecular components with ALEX2 Allergy Explorer testing, was performed. The statistical analysis of results was performed with these methods: TURF (total unduplicated reach and frequency), best reach and frequency by group size, two-sided tests, Fisher's exact test, and chi-square test (at an expected minimum frequency of at least 5). RESULTS: Altogether, 100 atopic dermatitis patients were examined: 48 men, 52 women, the average age 40.9 years, min. age 14 years, max. age 67 years. The high and very high level of specific IgE was reached in 75.0% of patients to 18 molecular components: from PR-10 proteins (Aln g 1, Bet v 1, Cor a1.0103, Cor a1.0401, Fag s 1), lipocalin (Can f 1), NPC2 family (Der f 2, Der p 2), uteroglobin (Fel d 1), from Alternaria alternata (Alt a 1), Beta expansin (Lol p 1, Phl p 1), molecular components from Timothy, cultivated rye (Secc pollen) and peritrophin-like protein domain Der p 23. The high and very high level of specific IgE to other lipocalins (Fel d 7, Can f 4), to arginine kinase (Bla g 9, German cockroach), and to allergen extracts Art v (mugwort), and Cyn d (Bermuda grass) reached 52.0% of patients. The severity of AD is in significant relation to the sensitization to molecular components of storage mites (Gly d 2, Lep d 2-NPC2 family), lipocalins (Can f 1, Can f 2, Can f 4, and Can f 6), arginine kinase (Asp f 6, Bla g 9, Der p 20, Pen m 2), uteroglobin (Fel d 1, Ory c 3), Mn superoxide dismutase (Mala s 11), PR-10 proteins (Fag s 1, Mal d 1, Cor a 1.0401, Cor a 1.0103), molecular components of the peritrophin-like domain (Der p 21, Der p 23), and to Secc pollen. In the subgroup of patients suffering from bronchial asthma, the significant role play molecular components from house dust mites and storage mites (Lep d 2, Der p 2, Der f 2-NPC2 family), cysteine protease (Der p 1), peritrophin-like protein domain (Der p 21, Der p 23), enolase from Alternaria alternata (Alt a 6), and Beta expansin Phl p 1. CONCLUSION: The results of our study demonstrate the detailed profile of sensitization to allergens reagents (allergen extract and molecular components) in patients with atopic dermatitis. We show the significance of disturbed epidermal barrier, resulting in increased penetration of allergens. We confirmed the significant relationship between the severity of AD, the occurrence of bronchial asthma and allergic rhinitis, and high levels of specific IgE to allergen reagents. Our results may be important for regime measures and immunotherapy; Der p 23 shall be considered as an essential component for the diagnosis and specific immunotherapy of house dust mite allergy.

Department of Clinical Immunology and Allergy Faculty Hospital and Medical Faculty of Charles University 50002 Hradec Králové Czech Republic

Department of Dermatology and Venereology Faculty Hospital and Medical Faculty of Charles University 50002 Hradec Králové Czech Republic

Department of Informatics and Quantitative Methods Faculty of Informatics and Management University of Hradec Kralove 50003 Hradec Králové Czech Republic

Department of Medical Biophysic Medical Faculty of Charles University 50002 Hradec Králové Czech Republic

Zobrazit více v PubMed

Czarnowicki T., Krueger J., Guttman-Yassky E. Novel concepts of prevention and treatment of atopic dermatitis through barrier and immune manipulations with implications for the atopic march. J. Allergy Clin. Immunol. 2017;139:1723–1734. doi: 10.1016/j.jaci.2017.04.004. PubMed DOI

Paller A., Spergel J., Mina-Osorio P., Irvine A. The atopic march and atopic multimorbidity: Many trajectories, many pathways. J. Allergy Clin. Immunol. 2019;143:46–55. doi: 10.1016/j.jaci.2018.11.006. PubMed DOI

Illi S., von Mutius E., Lau S., Nickel R., Grüber C., Niggemann B., Wahn U. The Multicenter Allergy Study Gro The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J. Allergy Clin. Immunol. 2004;113:925–931. doi: 10.1016/j.jaci.2004.01.778. PubMed DOI

Tokura Y. Evolution of Atopic Dermatitis in the 21st Century. Springer; Singapore: 2018. pp. 181–199. Extrinsic and Intrinsic Atopic Dermatitis.

Burbank A.J., Sood A.K., Kesic M.J., Peden D.B., Hernandez M.L. Environmental determinants of allergy and asthma in early life. J. Allergy Clin. Immunol. 2017;140:1–12. doi: 10.1016/j.jaci.2017.05.010. PubMed DOI PMC

Saglani S., Gregory L.G., Manghera A.K. Inception of early-life allergen-induced airway hyperresponsiveness is reliant on IL-13(+)CD4(+) T cells. Sci. Immunol. 2018;3:eaan4128. doi: 10.1126/sciimmunol.aan4128. PubMed DOI PMC

Tovey E.R., Almqvist C., Li Q., Crisafulli D., Marks G.B. Nonlinear relationship of mite allergen exposure to mite sensitization and asthma in a birth cohort. J. Allergy Clin. Immunol. 2008;122:114–118. doi: 10.1016/j.jaci.2008.05.010. PubMed DOI

Zakzuk J., Mercado D., Bornacelly A. Hygienic conditions influence sensitization to Blomia tropicalis allergenic components: Results from the FRAAT birth cohort. Pediatr. Allergy Immunol. 2019;30:172–178. doi: 10.1111/pai.13004. PubMed DOI

Matricardi P.M., Kleine-Tebbe J., Hoffmann H.J., Valenta R., Hilger C., Hofmaier S., Aalberse R.C., Agache I., Asero R., Ballmer-Weber B., et al. EAACI molecular Allergology User’s guide. Pediatr. Allergy Immunol. 2016;27(Suppl. S23):1–250. doi: 10.1111/pai.12563. PubMed DOI

Pulsawat P., Soongrung T., Satitsuksanoa P. The house dust mite allergen Der p 5 binds lipid ligands and stimulates airway epithelial cells through a TLR2-dependent pathway. Clin. Exp. Allergy. 2019;49:378–390. doi: 10.1111/cea.13278. PubMed DOI

Soongrung T., Mongkorntanyatip K., Peepim T. The Blomia tropicalis allergen Blot 7 stimulates innate immune signalling pathways through TLR2. Clin. Exp. Allergy. 2018;48:464–474. doi: 10.1111/cea.13098. PubMed DOI

Satitsuksanoa P., Kennedy M., Gilis D. The minor house dust mite allergen Der p 13 is a fatty acid-binding protein and an activator of a TLR2-mediated innate immune response. Allergy. 2016;71:1425–1434. doi: 10.1111/all.12899. PubMed DOI

Resch Y., Blatt K., Malkus U. Molecular, Structural and Immunological Characterization of Der p 18, a Chitinase-Like House Dust Mite Allergen. PLoS ONE. 2016;11:e0160641. PubMed PMC

Zakzuk J., Benedetti I., Fernandez-Caldas E., Caraballo L. The influence of chitin on the immune response to the house dust mite allergen Blo t 12. Int. Arch. Allergy Immunol. 2014;163:119–129. doi: 10.1159/000356482. PubMed DOI

Trompette A., Divanovic S., Visintin A. Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein. Nature. 2009;457:585–588. doi: 10.1038/nature07548. PubMed DOI PMC

Hewitt C.R., Horton H., Jones R.M., Pritchard D.I. Heterogeneous proteolytic specificity and activity of the house dust mite proteinase allergen Der p, I. Clin. Exp. Allergy. 1997;27:201–207. doi: 10.1111/j.1365-2222.1997.tb00694.x. PubMed DOI

Anto J.M., Bousquet J., Akdis M., Auffray C., Keil T., Momas I., Postma D.S., Valenta R., Wickman M., Cambon-Thomsen A., et al. Mechanisms of the development of allergy (MeDALL): Introducing novel concepts in allergy phenotypes. J. Allergy Clin. Immunol. 2017;139:388–399. doi: 10.1016/j.jaci.2016.12.940. PubMed DOI

van Hage M., Hamsten C., Valenta R. ImmunoCAP assays: Pros and cons in allergology. J. Allergy Clin. Immunol. 2017;140:974–977. doi: 10.1016/j.jaci.2017.05.008. PubMed DOI

Heffler E., Puggioni F., Peveri S., Montagni M., Canonica G.W., Melioli G. Extended IgE profile based on an allergen macroarray: A novel tool for precision medicine in allergy diagnosis. World Allergy Organ. J. 2018;11:7. doi: 10.1186/s40413-018-0186-3. PubMed DOI PMC

Steering Committee Authors. Review Panel Members A WAO—ARIA—GA2LEN consensus document on molecular-based allergy diagnosis (PAMD@): Update 2020. World Allergy Organ. J. 2020;13:100091. PubMed PMC

Čelakovská J., Bukač J., Vaňková R., Krcmova I., Krejsek J., Andrýs C. ISAC multiplex testing—results of examination in 100 patients suffering from atopic dermatitis. Food Agric. Immunol. 2020;31:1014–1035. doi: 10.1080/09540105.2020.1799947. DOI

Čelakovská J., Bukač J., Vaňková R., Krcmova I., Krejsek J., Andrýs C. Cluster analysis of molecular components in 100 patients suffering from atopic dermatitis according to the ISAC Multiplex testing. Food Agric. Immunol. 2020;31:827–848. doi: 10.1080/09540105.2020.1776224. DOI

Di Fraia M., Arasi S., Castelli S. A new molecular multiplex IgE assay for the diagnosis of pollen allergy in Mediterranean countries: A validation study. Clin. Exp. Allergy. 2019;49:341–349. doi: 10.1111/cea.13264. PubMed DOI

Melioli G., Bonifazi F., Bonini S. The ImmunoCAP ISAC molecular allergology approach in adult multi-sensitized Italian patients with respiratory symptoms. Clin. Biochem. 2011;44:1005–1011. doi: 10.1016/j.clinbiochem.2011.05.007. PubMed DOI

Weghofer M., Grote M., Resch Y., Casset A., Kneidinger M., Kopec J., Thomas W.R., Fernández-Caldas E., Kabesch M., Ferrara R., et al. Identification of Der p 23, a peritrophin-like protein, as a new major Dermatophagoides pteronyssinus allergen associated with the peritrophic matrix of mite fecal pellets. J. Immunol. 2013;190:3059–3067. doi: 10.4049/jimmunol.1202288. PubMed DOI PMC

Flöistrup H., Swartz J., Bergström A., Alm J.S., Scheynius A., van Hage M., Waser M., Braun-Fahrländer C., Schram-Bijkerk D., Huber M., et al. Allergic disease and sensitization in Steiner school children. J. Allergy Clin. Immunol. 2006;117:59–66. doi: 10.1016/j.jaci.2005.09.039. PubMed DOI

Bousquet J., Lockey R., Malling H.J., Alvarez-Cuesta E., Canonica G.W., Chapman M.D., Creticos P.J., Dayer J.M., Durham S.R., Demoly P., et al. Allergen immunotherapy: Therapeutic vaccines for allergic diseases—World Health Organization. American academy of Allergy, Asthma and Immunology. Ann. Allergy Asthma Immunol. 1998;81:401–405. doi: 10.1016/S1081-1206(10)63136-5. PubMed DOI

Carvalho Kdos A., de Melo-Neto O.P., Magalhães F.B., Ponte J.C., Felipe F.A., dos Santos M.C., dos Santos Lima G., Cruz Á.A., Pinheiro C.S., Pontes-de-Carvalho L.C., et al. Blomia tropicalis Blo t 5 and Blo t 21 recombinant allergens might confer higher specificity to serodiagnostic assays than whole mite extract. BMC Immunol. 2013;27:11. doi: 10.1186/1471-2172-14-11. PubMed DOI PMC

Pytelková J., Lepšík M., Sanda M., Talacko P., Marešová L., Mareš M. Enzymatic activity and immunoreactivity of Aca s 4, an alpha-amylase allergen from the storage mite Acarus siro. BMC Biochem. 2012;13:3. doi: 10.1186/1471-2091-13-3. PubMed DOI PMC

Banerjee S., Resch Y., Chen K., Swoboda I., Focke-Tejkl M., Blatt K., Novak N., Wickman M., van Hage M., Ferrara R., et al. Der p 11 is a major allergen for house dust miteallergic patients suffering from atopic dermatitis. J. Investig. Dermatol. 2015;135:102–109. doi: 10.1038/jid.2014.271. PubMed DOI PMC

Holzweber F., Svehla E., Fellner W. Inhibition of IgE binding to cross-reactive carbohydrate determinants enhances diagnostic selectivity. Allergy. 2013;68:1269–1277. doi: 10.1111/all.12229. PubMed DOI PMC

Biedermann T., Winther L., Till S.J., Panzner P., Knulst A., Valovirta E. Birch pollen allergy in Europe. Allergy. 2019;74:1237–1248. doi: 10.1111/all.13758. PubMed DOI

Panzner P., Vachová M., Vítovcová P., Brodská P., Vlas T. A comprehensive analysis of middle-european molecular sensitization profiles to pollen allergens. Int. Arch. Allergy Immunol. 2014;164:74–82. doi: 10.1159/000362760. PubMed DOI

Panzner P., Vachová M., Vlas T., Vítovcová P., Brodská P., Malý M. Cross-sectional study on sensitization to mite and cockroach allergen components in allergy patients in the Central European region. Clin. Transl. Allergy. 2018;8:1–9. doi: 10.1186/s13601-018-0207-x. PubMed DOI PMC

Vachová M., Panzner P., Vlas T., Vítovcová P. Analysis of Sensitization Profiles in Central European Allergy Patients Focused on Animal Allergen Molecules. Int. Arch. Allergy Immunol. 2020;181:278–284. doi: 10.1159/000505518. PubMed DOI

Cabanas R., Lopez-Serrano M.C., Carreira J. Importance of albumin in cross-reactivity among cat, dog and horse allergens. J. Investig. Allergol. Clin. Immunol. 2000;10:71–77. PubMed

Basagana M., Bartolome B., Pastor C. Allergy to human seminal fluid: Cross-reactivity with dog dander. J. Allergy Clin. Immunol. 2008;121:233–239. doi: 10.1016/j.jaci.2007.10.008. PubMed DOI

Khurana T., Newman-Lindsay S., Young P.R., Slater J.E. The NPC2 protein: A novel dog allergen. Ann. Allergy Asthma Immunol. 2016;116:440–446.e442. doi: 10.1016/j.anai.2016.02.006. PubMed DOI

Konradsen J.R., Fujisawa T., van Hage M. Allergy to furry animals: New insights, diagnostic approaches, and challenges. J. Allergy Clin. Immunol. 2015;135:616–625. doi: 10.1016/j.jaci.2014.08.026. PubMed DOI

Asarnoj A., Hamsten C., Waden K. Sensitization to cat and dog allergen molecules in childhood and prediction of symptoms of cat and dog allergy in adolescence: A BAMSE/MeDALL study. J. Allergy Clin. Immunol. 2016;137:813–821.e817. doi: 10.1016/j.jaci.2015.09.052. PubMed DOI PMC

Bjerg A., Winberg A., Berthold M., Mattsson L., Borres M.P., Ronmark E. A population-based study of animal component sensitization, asthma, and rhinitis in schoolchildren. Pediatr. Allergy Immunol. 2015;26:557–563. doi: 10.1111/pai.12422. PubMed DOI

Mittermann I., Wikberg G., Johansson C., Lupinek C., Lundeberg L., Crameri R., Valenta R., Scheynius A. IgE sensitization profiles differ between adult patients with severe and moderate atopic dermatitis. PLoS ONE. 2016;11:e0156077. doi: 10.1371/journal.pone.0156077. PubMed DOI PMC

Röckmann H., van Geel M., Knulst A.C., Huiskes J., Bruijnzeel-Koomen C., de Bruin-Weller M. Food allergen sensitization pattern in adults in relation to severity of atopic dermatitis. Clin. Transl. Allergy. 2014;4:9. doi: 10.1186/2045-7022-4-9. PubMed DOI PMC

Hanifin J., Rajka G. Diagnostic features of atopic dermatitis. Acta Derm. Venereol. 1980;92:44–47.

European Task Force on Atopic Dermatitis Severity scoring of atopic dermatitis: The SCORAD Index (consensus report of the European Task Force on Atopic Dermatitis) Dermatology. 1993;186:23–31. doi: 10.1159/000247298. PubMed DOI

Jakob T., Forstenlechner P., Matricardi P., Kleine-Tebbe J. Molecular allergy diagnostics using multiplex assays: Methodological and practical considerations for use in research and clinical routine. Allergol. J. Int. 2015;24:320–332. doi: 10.1007/s40629-015-0087-8. PubMed DOI PMC

Choi J., Roh J., Lee J. Clinical Availability of Component-Resolved Diagnosis Using Microarray Technology in Atopic Dermatitis. Ann. Dermatol. 2014;26:437–446. doi: 10.5021/ad.2014.26.4.437. PubMed DOI PMC

Wang X., Du K., She W., Ouyang Y., Sima Y., Liu C., Zhang L. Recent advances in the diagnosis of allergic rhinitis. Expert Rev. Clin. Immunol. 2018;14:957–964. doi: 10.1080/1744666X.2018.1530113. PubMed DOI